Additionally, in hepatoma, ApoL1 expression can be activated by a high level of interferon regulatory factor (IRF) 1, IRF2 and Sp1, all of which are transcription factors that can bind the ApoL1 promoter region (Wang et al., 2020a). The gene discussed is APOL1; the disease is hepatocellular carcinoma.